Gopalasamudram Narayana Ramachandran was a brilliant Indian scientist. His work revolutionized protein structure and medical ...

Stakeholders from across policy, regulatory agencies, research institutions, healthcare, and civil society, among others, on ...

Lumen is led by CEO Brian Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts, the former head of basic sciences at the Fred Hutchinson Cancer ...

The scale of the problem is staggering. In 2019, Medicare spent $256 million on skin substitutes. By 2024, that number had ...

In this week’s edition of InnovationRx, we look at the Nobel Prize winners in medicine, Amgen’s direct-to-consumer effort, ...

Scientists discovered that Gila monster venom contains a compound that slows digestion. It led to one of the biggest medical ...

Researchers at Texas A&M’s Health Science Center have developed a photo-inducible binary interaction tool, or PhoBIT, system ...

Any pharmaceutical company as large and sprawling as AbbVie (ABBV 1.41%) never stops being busy, from pushing investigational drugs along the development pipeline to shipping bloc ...

CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges ...

Spending time with others—even while reading or cleaning—may boost happiness, a new study shows. Experts explain why this ...

Stories like Mendosa’s have become commonplace in the age of Ozempic. According to a 2024 Kaiser Family Foundation survey, ...

On his first business trip to Vietnam, Russell Miller, vice president of Global Sales and Marketing at Enzene Biosciences, shared with VIR’s Ho Ha the company’s ambition to reshape the global ...